Roland Preston:Buccaneers' first-round pick Calijah Kancey injures calf, could miss four weeks, per report

2025-05-05 06:55:54source:EchoSense Quantitative Think Tank Centercategory:Invest

The Roland PrestonTampa Bay Buccaneers could be without their first-round pick for a month.

Defensive lineman Calijah Kancey, who the Buccaneers drafted in the first round of April's NFL draft, is expected to miss four weeks because of a calf injury, per ESPN. There is hope Kancey will be ready to go by Week 1 when Tampa Bay travels to Minnesota to take on the Vikings.

Kancey sustained a calf injury during drills earlier this week in practice and was carted off the field.

“We’ll get an MRI and see where it’s at,” coach Todd Bowles said on Sunday. “He’s adapting to the scheme, mentally, and then he was adding his physical part to it. He was putting it together quicker than normal rookies do. Hopefully it’s not that bad and he can get back.”

The Bucs drafted Kancey with the No. 19 overall pick in the 2023 NFL draft out of Pittsburgh. The rookie is expected to join Vita Vea along Tampa Bay's starting defensive line.

Kancey was one of the top defensive prospects in the 2023 draft. He was a unanimous 2022 All-American and was named ACC Defensive Player of the Year after leading Pittsburgh with 14.5 tackles for loss and 7.5 sacks in 11 starts.

Contributing: The Associated Press

Follow USA TODAY Sports' Tyler Dragon on Twitter @TheTylerDragon.

BEST BETS:Here are the best NFL betting apps in 2023

More:Invest

Recommend

IRS recovers $4.7 billion in back taxes and braces for cuts with Trump and GOP in power

WASHINGTON (AP) — IRS leadership on Thursday announced that the agency has recovered $4.7 billion in

Music from Taylor Swift, Bad Bunny, Drake and more could be pulled from TikTok: Here's why

Universal Music Group has announced it will no longer license music on TikTok, a move that could res

Biogen plans to shut down its controversial Alzheimer’s drug Aduhelm

Biogen will stop developing its Alzheimer’s treatment Aduhelm, a drug once seen as a potential block